NCT01990300View on ClinicalTrials.gov

Alogliptin/Pioglitazone (Liovel) Combination Tablets Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus

CompletedOBSERVATIONAL
Enrollment

3,281

Participants

Timeline

Start Date

November 28, 2011

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Alogliptin/Pioglitazone

Alogliptin/Pioglitazone combination tablets

Trial Locations (1)

Unknown

Someplace

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT01990300 - Alogliptin/Pioglitazone (Liovel) Combination Tablets Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter